RSS   Newsletter   Contact   Advertise with us

Nestle buys Allergan business to expand in medical nutrition

Share on Twitter Share on LinkedIn
Christian Fernsby ▼ | January 27, 2020
Nestle today announced that it has entered into an asset purchase agreement with Allergan to acquire the gastrointestinal medication Zenpep.
Acquisition   Nestle
This move aims to expand the company's medical nutrition business and complement its portfolio of therapeutic products.

Topics: Nestle Allergan

Zenpep, available in the United States, is a medication for people who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates.

Zenpep's 2018 net sales were USD 237 million.

The deal is expected to be finalized concurrent with the merger of Allergan and AbbVie.

Financial details of this acquisition are not being disclosed.

Nestlé will take ownership of Zenpep upon closing the transaction, with customary transition support from the seller.